Scarica l'app Stockscreener
25.36
3.48%
-0.95
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? - Yahoo Finance
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile (NASDAQ:AMPH) - Seeking Alpha
Is FDA‑Cleared U.S.‑Made Teriparatide Pen Altering The Investment Case For Amphastar Pharmaceuticals (AMPH)? - simplywall.st
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $44,623.53 in Stock - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $62,881.92 in Stock - MarketBeat
Amphastar Pharmaceuticals Director Sells Over 4,000 Shares - TradingView — Track All Markets
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 4.8%Still a Buy? - MarketBeat
Amphastar stock rises after FDA approval of teriparatide injection - Investing.com
Amphastar Announces FDA Approval for Teriparatide Injection - Weatherford Democrat
Amphastar (NASDAQ: AMPH) wins FDA OK for teriparatide pen in $585M US market - Stock Titan
What analysts say about Amphastar Pharmaceuticals Inc 29A stockTechnical Pattern Recognition & Access Free Tools and Start Investing - earlytimes.in
Dir Petersen Files To Sell 4,163 Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView — Track All Markets
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded to "Hold" at Barclays - MarketBeat
Is Amphastar Pharmaceuticals Mispriced After a Tough Year and Promising Cash Flow Outlook in 2025? - Sahm
Barclays Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Equal-Weight Recommendation - Nasdaq
Amphastar Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for AMPH - Nasdaq
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Barclays - MarketBeat
Barclays Initiates Amphastar Pharmaceuticals at Equalweight With $30 Price Target - marketscreener.com
Marshall Wace LLP Sells 183,037 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Falls 5.2% in Past Week as One-year Earnings and Shareholder Returns Continue Downward Trend - 富途牛牛
American Century Companies Inc. Sells 74,832 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Is Amphastar Pharmaceuticals Stock Built to Withstand a Pullback? - Trefis
Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Quantbot Technologies LP - MarketBeat
Why (AMPH) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Would You Still Hold Amphastar Pharmaceuticals Stock If It Fell 30%? - Trefis
Capital Fund Management S.A. Takes $931,000 Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - Yahoo Finance
How Amphastar Pharmaceuticals Inc. (29A) stock expands through international marketsOptions Play & Free Community Supported Trade Ideas - Newser
Will Amphastar Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why - The Globe and Mail
AMPH: Shifting to proprietary and biosimilar drugs, with major launches and global expansion ahead - TradingView — Track All Markets
Will Amphastar Pharmaceuticals Inc. (29A) stock benefit from infrastructure bill2025 Price Targets & Capital Protection Trade Alerts - Newser
Trend Recap: How strong is Amphastar Pharmaceuticals Inc stock revenue growth - BỘ NỘI VỤ
Will Amphastar Pharmaceuticals Inc. (29A) stock deliver stable dividendsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Is Amphastar Pharmaceuticals Inc. stock a good choice for value investorsTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Is Amphastar Pharmaceuticals Inc. (29A) stock at risk of policy regulationQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Can Amphastar Pharmaceuticals Inc. (29A) stock double in coming years2025 Price Targets & Real-Time Price Movement Reports - Newser
Creative Planning Acquires 22,493 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Geode Capital Management LLC Buys 18,161 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed? - Sahm
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress - Yahoo Finance
VP Zhou Files To Sell 20,000 Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
SG Americas Securities LLC Acquires Shares of 24,448 Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar’s (AMPH) Q3 Earnings Beat Amid Margin Pressure Shift Its Competitive Narrative? - Sahm
Does Amphastar’s New Product Approvals Signal a Turning Point for the Stock in 2025? - Sahm
Magnetar Financial LLC Invests $306,000 in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar (AMPH) Q3 2025 Earnings Call Transcript - The Globe and Mail
Richard Prins Sells 4,179 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Understanding Momentum Shifts in (AMPH) - news.stocktradersdaily.com
Amphastar pharma director Prins sells $113,253 in shares By Investing.com - Investing.com Canada
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Amphastar Pharmaceuticals Director Sells Shares - TradingView
Dir Prins Sells 4,179 ($113.3K) Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView
Amphastar Pharmaceuticals- Growth has been impressive, Can it continue? - Yahoo Finance
Amphastar Pharmaceuticals- Growth has been impressive, Can it c - GuruFocus
Dynamic Technology Lab Private Ltd Takes Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference - standard-journal.com
0.89%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):